A need to stand united: reply to the WAME secretary
Abstract
I believe Dr Winker and I agree more than differ about the need for authors of medical journal reports of randomised controlled trial (RCT) findings to acknowledge when they make post hoc adjustments to the original content that they submit to obtain FDA marketing approval for a new drug or medical device.
Keywords
N/A
Refbacks
There are currently no refbacks.
Thomas Manuel, Impact factors fail in evaluating scientists. Why does the UGC still use them? The Wire, April 18, 2018: 
